Two biotech companies, Neumora and RayzeBio, hashed out their IPO plans Monday morning, detailing hopes to raise around $227 million and $206 million, respectively, in their Nasdaq debuts.
The companies could enter the public market as soon as this week. Both aim to price their shares between $16 and $18….
Click here to view original post
